Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04544774

The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy

Sponsor: Universitaire Ziekenhuizen KU Leuven

View on ClinicalTrials.gov

Summary

This prospective multicentric academic NAPT study aims to compile a database of all patients who initiate immunotherapy. The NAPT will take place before, during and after AIT to evaluate the cost and effectiveness of the treatment. The study consists of 4 visits and 2 telephone contacts that are repeated annually for 3 years. This study will be conducted in 2 hospitals: UZ Leuven and AZ ST. Jan Brugge on the consultation Ear, Nose and Throat Diseases (ENT) and the department of Internal Medicine / Allergology

Official title: The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy: An Academic Multicentre Clinical Study

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

OBSERVATIONAL

Enrollment

200

Start Date

2020-07-16

Completion Date

2026-12

Last Updated

2026-05-01

Healthy Volunteers

Not specified

Interventions

DRUG

AIT

AIT for airborn allergens (SCIT/SLIT)

DIAGNOSTIC_TEST

NAPT

NAPT test with airborn allergens ( HDM, Threes, Grasses)

Locations (2)

UZ Leuven

Leuven, Vlaam Brabant, Belgium

AZ Sint-Jan

Bruges, Belgium